Related Experiment Video
Updated: Mar 22, 2026
08:17
A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
15.6K
Optimized Animal Model of Cyclophosphamide-induced Bone Marrow Suppression
Lizhi Feng1,2, Qiuju Huang1, Zhiying Huang1
1International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
Basic & Clinical Pharmacology & Toxicology
|April 11, 2016
Summary
This study optimized a chemotherapy-induced myelosuppression animal model using cyclophosphamide (CTX) in mice. High-dose CTX treatment for 10 days effectively suppressed bone marrow, proving useful for research.
Area of Science:
- Pharmacology
- Hematology
- Toxicology
Background:
- Myelosuppression is a severe side effect of chemotherapy, impacting patient quality of life.
- Developing a reliable animal model for chemotherapy-induced bone marrow suppression is crucial for research.
Purpose of the Study:
- To establish and optimize an animal model for chemotherapy-induced bone marrow suppression.
- To evaluate the effects of cyclophosphamide (CTX) on mice to create a standardized model.
Main Methods:
- C57BL/6 mice were administered intermediate and high doses of cyclophosphamide (CTX) for 10 days.
- Body weight, thymus and spleen indices, blood cell counts (WBC, RBC, PLT), and bone marrow cell markers (Sca1, CD34) were assessed on days 2, 7, and 14.
Main Results:
- CTX treatment significantly reduced body weight and thymus/spleen ratios, damaging their structures.
- White blood cell and red blood cell counts decreased, while platelet counts increased.
- Bone marrow Sca1 expression showed dynamic changes, and CD34 expression decreased post-CTX treatment.
Conclusions:
- High-dose cyclophosphamide (CTX) treatment for 10 days in mice provides an optimized and effective model for studying chemotherapy-induced bone marrow suppression.
